Full-Time
Staff Engineer
Automation & Controls
Posted on 11/1/2025
Stryker
10,001+ employees
Manufactures orthopedic and surgical medical devices
No salary listed
Limerick, Ireland
In Person
 Electrical Engineering (1) |
|---|
- Level 8 Degree in Electrical/Electronic Engineering, Computer Science or related field with equivalent technical experience is required.
- Has minimum of 4-6 years, software and controls experience in a manufacturing environment.
- Demonstrated ability to provide technical solutions for complex problems through automation systems knowledge.
- Proven Project Management skills through the delivery of Automation and or Digitalisation projects.
- Strong technical background is essential for this role (PLC, HMI, Robotics, GAMP, GMP).
- Experience with Allen Bradley and Siemens controls systems would be advantageous.
- Some experience of scripting programming languages would be advantageous.
- Some experience of Object Oriented Programming and SQL Server DB design is advantageous.
- Working knowledge of Ignition SCADA platform and Cognex vision systems is beneficial.
- Good knowledge of ISA95 and ISA88 design/implementation.
- Strong communication and influencing skills with both internal and external stakeholders.
- Capable of providing technical leadership, influencing and providing technical direction to Engineers, Technicians and team members as required.
- Capable of working autonomously or as part of a multi-disciplined team in an aggressive, dynamic and results motivated environment.
- A team player, with a flexible approach.
- Must be willing to source, investigate and implement technological and automation advances.
- Understanding of FDA, BSI and regulatory software validation requirements.
- Travel Percentage: 10%
- Provide day to day support to operations for Automation and Controls components within the manufacturing process.
- Identify, evaluate & implement opportunities for continuous improvement.
- Provide Technical leadership to the wider engineering team in the field of process automation.
- Provides input and help in the selection of new technologies to improve plant efficiencies.
- Participates within project teams, provides technical support and makes informed decisions on hardware and architecture selection.
- Proactively resolve technical issues before they impact business priorities.
- Analyse, understand, fault-find and modify where necessary automation software in line with the sites quality management system.
- Develop, test and install control’s software as part of a highly automated and validated production environment.
- Develop and integrate software applications with automated equipment into existing business intelligence digital tools used onsite.
- Champion digital reporting tools and visualisations that are thorough, detailed and able to be comprehended by the end user
- Take ownership of the software applications and hardware used to house the sites digital business intelligence tools, ensuring optimum performance.
- Develop User, Functional and Detailed Design Specifications.
- Work within a cross functional multidiscipline team environment.
- Ability to use data and metrics to anticipate problems and make data driven decisions in response.
- Support process development and cost reduction activities within the business units.
- Provide guidance on integrating, testing, evaluating and modifying automated systems and seeing the process through from beginning to end.
- Provide on the job training/support to new team members.
- All other duties as assigned.
- Experience with automation platforms and industry standards such as good manufacturing practices and GAMP is beneficial.
- Experience with data analytics, visualization, reporting and dashboard design would be advantageous.
- ISO 9001 knowledge and experience in quality systems would be beneficial.
- Experience with regulatory compliance and FDA or BSI validation would be advantageous.
- Experience in industrial networking and cybersecurity concepts would be beneficial.
Stryker designs, manufactures, and sells medical devices across multiple areas, including surgical equipment, neurotechnology, and orthopedic implants, to hospitals and clinics worldwide. Its products are developed through engineering and clinical input, then manufactured and distributed to healthcare providers who use them during procedures to improve patient care and surgical efficiency. Stryker differentiates itself from competitors with a broad, integrated portfolio, a global sales and service network, and a strong emphasis on quality and ongoing product development to support safer, more efficient procedures. The company’s goal is to advance patient outcomes by delivering reliable, effective medical devices that expand access to care globally.
Company Size
10,001+
Company Stage
IPO
Headquarters
Kalamazoo, Michigan
Founded
1941
Simplify's Take
What believers are saying
- Robotic surgery leadership drives double-digit sales growth through 2025.
- India Trident II launch targets aging population's rising hip surgeries.
- Peripheral vascular expansion via IVL meets growing arterial disease demand.
What critics are saying
- Handala cyberattack on March 11 delays ortho supply chain 3-6 months.
- Zimmer Biomet Persona IQ erodes ortho share with real-time analytics.
- J&J Velys captures 25% more knee procedures from Mako in 6-12 months.
What makes Stryker unique
- Stryker holds 39.1% US market share in orthopedic product manufacturing.
- Trident II Acetabular System integrates Mako SmartRobotics for hip replacements.
- Amplitude Vascular Systems acquisition adds CO₂ IVL for peripheral arteries.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Medical & prescription plans
Supplemental health benefits
Flexible Spending accounts
Employee Assistance Program
Short-term & long-term disability
Tuition reimbursement
401(k) plan
Employee Stock Purchase Plan
Company News
Distalmotion targets ASC gynecology programs with new FDA filing Distalmotion has submitted a 510(k) application to the FDA seeking to expand the label of its Dexter robotic surgery system into additional gynecological indications, the company announced April 1. The filing covers sacrocolpopexy, sacrocervicopexy and endometriosis resection. Sacrocolpopexy and sacrocervicopexy are procedures used to treat pelvic…
Stryker Corporation has signed a definitive agreement to acquire Amplitude Vascular Systems, a Boston-based medical technology company developing next-generation intravascular lithotripsy technology for treating calcified peripheral arterial disease. Financial terms were not disclosed. AVS's technology uses pulsed CO₂-generated pressure waves delivered through a balloon catheter to fracture calcium deposits. The platform aims to enhance catheter deliverability, treatment speed and therapy efficiency. The acquisition will strengthen Stryker's peripheral vascular portfolio and expand its presence in arterial disease treatment. Stryker CEO Kevin Lobo said the deal advances the company's vision to build a comprehensive peripheral vascular platform addressing significant clinical needs. IVL technology is experiencing strong growth as physicians increasingly adopt it for calcium modification in complex cardiovascular procedures. The transaction remains subject to customary closing conditions.
Stryker has raised $120 million in a Series C round led by Ribbit Capital, valuing the medical technology company at $1.45 billion. The funding comes despite shares declining 7.6% over the past six months, outperforming the industry's 19.7% drop. The company delivered 11% organic sales growth in Q4 2025 and 10.3% for the full year, marking its fourth consecutive year of double-digit growth. Performance was broad-based across its Orthopaedics, MedSurg and Neurotechnology segments, driven by strong procedural volumes and favourable demographics. Stryker achieved over 100 basis points of operating margin expansion for the second consecutive year despite tariff pressures. The company enters 2026 with a robust capital equipment backlog, though rising interest costs and tariffs present near-term challenges. Analysts maintain a Hold rating on the stock.
Stryker shares fell 9% to $339 following a destructive cyberattack by Iranian-linked group Handala that wiped over 200,000 systems and disrupted manufacturing and shipping operations across 56,000 employees in 61 countries. The medical technology company confirmed disruptions to order processing but stated there was no indication of ransomware. Unlike typical ransomware attacks, this wiper attack permanently deleted data rather than holding it for ransom, complicating recovery efforts. The incident threatens Stryker's 8% to 9.5% organic growth guidance for 2026 if operations fail to normalise quickly. Stryker generated $25 billion in revenue in 2025 with $4.283 billion in free cash flow and holds $4 billion in cash. Analysts maintain a consensus price target of $424.89 with 22 buy ratings and no sell ratings among 30 covering analysts.
Stryker reported Q4 revenues of $7.17 billion, up 11.4% year-over-year and exceeding analyst expectations by 0.8%. The medical device manufacturer, which impacts over 150 million patients annually through its orthopaedics, surgical tools, neurotechnology and patient care solutions, delivered what CEO Kevin Lobo called "an outstanding finish to 2025". The company achieved double-digit sales and adjusted earnings per share growth for both the quarter and full year, whilst expanding adjusted operating margin by at least 100 basis points for the second consecutive year. Across the medical devices and supplies sector, the six diversified stocks tracked reported mixed Q4 results. As a group, revenues beat consensus estimates by 1.9%, though share prices have declined an average of 5.1% since the latest earnings announcements.